The above regimens should be given for 14 days. If sensitivity testing is not available, then the recommended regimen is the same as for CLA and MET resistance. Resistance to CLA should also be assumed if the patient has any prior exposure to this or other macrolide antibiotic. The strain should be assumed to be resistant to MET if the patient has been exposed to this antibiotic within the past few years. For dosing, refer to UpToDate table on antibiotic dosing for H. pylori in children.
From: Jones NL, Koletzko S, Goodman K, et al. Joint ESPGHAN/NASPGHAN Guidelines for the Management of Helicobacter pylori in Children and Adolescents (Update 2016). J Pediatr Gastroenterol Nutr 2017; 64:991. DOI:
10.1097/MPG.0000000000001594. Copyright © 2017 ESPGHAN and NASPGHAN. Adapted with permission from Wolters Kluwer Health. Unauthorized reproduction of this material is prohibited.